Target intelligence / Profile preview

Muscle basement membrane components and cell-surface receptors

Molecular classification
Extracellular matrix protein, Cell-surface receptor, Adhesion molecule
01

Overview

The muscle basement membrane and its associated cell-surface receptors form a critical structural and functional unit that maintains the integrity of skeletal and cardiac muscle fibers (Sanes, J. R., 2003, Nature Reviews Neuroscience). This complex includes extracellular matrix (ECM) proteins such as laminin-211, collagen IV, and perlecan, which interact with transmembrane receptors like the dystroglycan complex and alpha7beta1 integrin (Yurchenco, P. D., 2011, Cold Spring Harbor Perspectives in Biology). These interactions facilitate force transmission from the cytoskeleton to the ECM and initiate signaling pathways essential for cell survival and regeneration. Defects in these components, such as mutations in the LAMA2 or COL6 genes, lead to various forms of muscular dystrophy characterized by membrane fragility and progressive muscle wasting (Mercuri, E., et al., 2019, Nature Reviews Disease Primers). While not a single drug target, this system is the focus of numerous therapeutic strategies, including gene replacement, protein substitution, and the use of small molecules to stabilize the membrane or reduce secondary fibrosis. This entry is considered 'incorrect' as a single target because it encompasses a broad category of multiple distinct proteins and receptors rather than a specific molecular entity.

Other names
Muscle basal laminaMyofiber extracellular matrixDystrophin-associated glycoprotein complex (DAGC) interactorsMuscle ECM-receptor unit
02

Mechanism of action

Modulation of structural integrity, replacement of missing structural proteins, or inhibition of pro-fibrotic signaling within the extracellular matrix.

03

Biological functions

Structural supportForce transmissionCell-matrix adhesionSignal transductionMuscle fiber maintenance
04

Disease associations

Muscular dystrophyCongenital muscular dystrophyMyopathyMuscle fibrosis
05

Safety considerations

Immunogenicity of replacement proteinsOff-target effects on systemic ECMFibrosis exacerbationDelivery challenges to deep muscle tissue
06

Interacting drugs

Eteplirsen

4 more in the full profile.

07

Biomarkers

Serum creatine kinase (CK)Laminin subunit alpha-2 levelsCollagen VI expressionDystrophin expression

Beyond the preview

Go deeper on Muscle basement membrane components and cell-surface receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle basement membrane components and cell-surface receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call